Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6

Aim: Tramadol is widely used to treat acute, chronic, and neuropathic pain. Its primary active metabolite, O-desmethyltramadol (M1), is mainly responsible for its µ-opioid receptor-related analgesic effect. Tramadol is metabolized to M1 mainly by the cytochrome P450 (CYP) 2D6 enzyme, and to other me...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joomi, Yoo, Hee-Doo, Bae, Jung-Woo, Lee, Sooyeun, Shin, Kwang-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537040/
https://www.ncbi.nlm.nih.gov/pubmed/31213765
http://dx.doi.org/10.2147/DDDT.S199574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537040/
https://www.ncbi.nlm.nih.gov/pubmed/31213765
http://dx.doi.org/10.2147/DDDT.S199574

Ejemplares similares